Evidence map›Paper›PMID 33184222›Full record

ArticleGenes & development2020

DUSP11-mediated control of 5'-triphosphate RNA regulates RIG-I sensitivity.

Joon H Choi, James M Burke, Kayla H Szymanik, Upasana Nepal, Anna Battenhouse, Justin T Lau, Aaron Stark, Victor Lam, Christopher S Sullivan

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. YBX1 regulates RNA polymerase III transcripts to prevent inflammation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Y-box binding proteins in immunity and RNA virus infection.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Crosstalk between vault RNAs and innate immunity.Molecular biology reports · 2024
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Joon H ChoiDepartment of Molecular Biosciences, LaMontagne Center for Infectious Disease, The University of Texas at Austin, Austin Texas 78712, USA.
James M BurkeDepartment of Molecular Biosciences, LaMontagne Center for Infectious Disease, The University of Texas at Austin, Austin Texas 78712, USA.
Kayla H SzymanikDepartment of Molecular Biosciences, LaMontagne Center for Infectious Disease, The University of Texas at Austin, Austin Texas 78712, USA.
Upasana NepalDepartment of Molecular Biosciences, LaMontagne Center for Infectious Disease, The University of Texas at Austin, Austin Texas 78712, USA.
Anna BattenhouseDepartment of Molecular Biosciences, LaMontagne Center for Infectious Disease, The University of Texas at Austin, Austin Texas 78712, USA.
Justin T LauDepartment of Molecular Biosciences, LaMontagne Center for Infectious Disease, The University of Texas at Austin, Austin Texas 78712, USA.
Aaron StarkDepartment of Molecular Biosciences, LaMontagne Center for Infectious Disease, The University of Texas at Austin, Austin Texas 78712, USA.
Victor LamDepartment of Molecular Biosciences, LaMontagne Center for Infectious Disease, The University of Texas at Austin, Austin Texas 78712, USA.
Christopher S SullivanDepartment of Molecular Biosciences, LaMontagne Center for Infectious Disease, The University of Texas at Austin, Austin Texas 78712, USA.
The University of Texas at Austin · US

Funding

Elucidating How Tri-phosphatase DUSP11 Controls HCV Infection and Hepatocyte InflammationR01AI134980 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI RANDALL, GLENN C, SULLIVAN, CHRISTOPHER S. · 2018 to 2021
$1.8M
Role of RNAi factor DUSP11 in ocular biology and diseaseR21EY028272 · NEI · UNIVERSITY OF TEXAS AT AUSTIN · PI SULLIVAN, CHRISTOPHER S. · 2017 to 2018
$420k
NEI NIH HHS R21 EY028272NIAID NIH HHS R01 AI134980
6 · The paper itself

Abstract

Deciphering the mechanisms that regulate the sensitivity of pathogen recognition receptors is imperative to understanding infection and inflammation. Here we demonstrate that the RNA triphosphatase dual-specificity phosphatase 11 (DUSP11) acts on both host and virus-derived 5'-triphosphate RNAs rendering them less active in inducing a RIG-I-mediated immune response. Reducing DUSP11 levels alters host triphosphate RNA packaged in extracellular vesicles and induces enhanced RIG-I activation in cells exposed to extracellular vesicles. Virus infection of cells lacking DUSP11 results in a higher proportion of triphosphorylated viral transcripts and attenuated virus replication, which is rescued by reducing RIG-I expression. Consistent with the activity of DUSP11 in the cellular RIG-I response, mice lacking DUSP11 display lower viral loads, greater sensitivity to triphosphorylated RNA, and a signature of enhanced interferon activity in select tissues. Our results reveal the importance of controlling 5'-triphosphate RNA levels to prevent aberrant RIG-I signaling and demonstrate DUSP11 as a key effector of this mechanism.

Indexed as

AnimalsCell LineDEAD Box Protein 58Dual-Specificity PhosphatasesHEK293 CellsHost-Pathogen InteractionsHumansImmunity, InnateInterferonsLiposomesMiceMice, Inbred C57BLPolyphosphatesRNARNA, ViralRNA VirusesDEAD Box Protein 58Dual-Specificity PhosphatasesDUSP11 protein, humanDusp11 protein, mouseInterferonsLiposomesPolyphosphatesRNARNA, Viraltriphosphoric acidDUSP11inflammationinnate immunitynoncoding RNARIG-I signalingtumor–stromal interactionvirus infection

Identifiers

PMID33184222
PMCPMC7706711
OpenAlexW3098486383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.